PNC Financial Services Group’s Vera Therapeutics VERA Stock Holding History

PNC Financial Services Group’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.26K	Buy	76 +14	+23%	+$522	﹤0.01%	4538
2026 Q1	$2.49K	Hold	62	–	–	﹤0.01%	4516
2025 Q4	$3.14K	Hold	62	–	–	﹤0.01%	4404
2025 Q3	$1.8K	Buy	+62	New	+$1.43K	﹤0.01%	4529
2024 Q4	–	Sell	-5	Closed	-$221	–	4932
2024 Q3	$221	Sell	5 -20	-80%	-$759	﹤0.01%	4671
2024 Q2	$905	Buy	25 +8	+47%	+$317	﹤0.01%	4447
2024 Q1	$733	Buy	17 +15	+750%	+$535	﹤0.01%	4433
2023 Q4	$31	Sell	2 -205	-99%	-$2.6K	﹤0.01%	4588
2023 Q3	$2.84K	Hold	207	–	–	﹤0.01%	4143
2023 Q2	$3.32K	Buy	+207	New	+$1.87K	﹤0.01%	4224

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

PNC Financial Services Group's VERA Position: Q2 2026 in Review

PNC Financial Services Group increased its Vera Therapeutics (VERA) stake by 23% in Q2 2026, buying an estimated $522 and bringing the position to 76 shares worth $3.26K. The position accounts for ﹤0.01% of the portfolio, ranked #4538.

PNC Financial Services Group first reported a position in VERA in Q2 2023 and has held it in 10 quarters since. The position peaked at $3.32K in Q2 2023. 56 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

PNC Financial Services Group held 76 shares of Vera Therapeutics worth $3.26K as of Q2 2026.
PNC Financial Services Group bought 14 Vera Therapeutics shares in Q2 2026, an estimated $522.
Vera Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4538 holding.
PNC Financial Services Group first reported a position in Vera Therapeutics in Q2 2023 and has held it in 10 quarters since.
PNC Financial Services Group's Vera Therapeutics position peaked at $3.32K in Q2 2023.
56 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.